CREDIT SUISSE AG/ - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 123 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$993,065
-12.7%
43,318
-37.2%
0.00%0.0%
Q2 2023$1,137,827
+15.4%
69,001
+24.8%
0.00%0.0%
Q1 2023$986,392
-28.6%
55,291
+16.6%
0.00%0.0%
Q4 2022$1,380,637
+58.9%
47,412
+33.6%
0.00%0.0%
Q3 2022$869,000
+752.0%
35,484
+44.7%
0.00%
Q2 2022$102,000
-67.5%
24,522
-10.1%
0.00%
Q1 2022$314,000
+11.0%
27,271
-4.0%
0.00%
Q4 2021$283,000
-15.5%
28,417
+11.1%
0.00%
Q3 2021$335,000
-28.3%
25,580
+7.5%
0.00%
Q2 2021$467,000
-13.7%
23,802
-6.5%
0.00%
Q1 2021$541,000
-58.9%
25,456
-42.5%
0.00%
-100.0%
Q4 2020$1,317,000
+256.9%
44,276
+159.5%
0.00%
Q3 2020$369,000
-55.3%
17,060
-54.0%
0.00%
-100.0%
Q2 2020$826,000
+284.2%
37,053
+162.1%
0.00%
Q1 2020$215,000
-38.0%
14,138
-6.7%
0.00%
Q4 2019$347,000
+42.2%
15,152
+34.0%
0.00%
Q3 2019$244,000
-21.5%
11,306
-20.3%
0.00%
Q2 2019$311,000
+19.2%
14,183
+48.7%
0.00%
Q1 2019$261,000
+12.0%
9,535
+9.9%
0.00%
Q4 2018$233,000
-50.0%
8,680
-45.6%
0.00%
Q3 2018$466,000
+69.5%
15,950
+81.3%
0.00%
Q2 2018$275,0008,7960.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$11,875,0002.75%
RA Capital Management 4,871,067$63,616,0000.88%
NEA Management Company, LLC 4,912,306$64,155,0000.76%
Samsara BioCapital, LLC 300,293$3,922,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,989,625$25,985,0000.51%
Baker Brothers Advisors 3,863,239$50,454,0000.22%
ACT CAPITAL MANAGEMENT, LLC 31,000$405,0000.21%
Rock Springs Capital Management LP 612,180$7,995,0000.17%
GILDER GAGNON HOWE & CO LLC 1,496,424$19,543,0000.10%
FEDERATED HERMES, INC. 3,011,053$39,324,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders